| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
>0.5 |
>128 |
0.25 － >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
396 |
| Staphylococcus aureus (methicillin-susceptible) |
>0.5 |
>128 |
0.25 － >128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.25 － 1 |
Cefpirome |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.25 － 2 |
Amoxicillin-clavulanate |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
371 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.25 － >64 |
Teicoplanin (Targocid) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Daptomycin + 25 μg/ml Ca++ |
67 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Quinupristin/Dalfopristin (Synercid) |
178 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
16 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
CB-181963 (CAB-175) |
273 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Cefuroxime (Kefurox, Zinacef) |
317 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
FK037 |
1491 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
67 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
214 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
396 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 4 |
Cefditoren (Spectracef) |
56 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － 16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
0.5 － >64 |
Vancomycin (Vancocyn, Lyphocin) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
1 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
109 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
273 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
89 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
1 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
1111 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.03 － 4 |
Amoxicillin-clavulanate |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.06 － 2 |
Ranbezolid (RBX 7644) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
≤0.06 － 2 |
Ranbezolid (RBX 7644) |
72 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.125 － 4 |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
1 |
2 |
0.125 － 64 |
Gentamicin (Gentamycin, Garamycin) |
178 |